ImmuMap is happy to announce results from this year’s MHC multimer proficiency panel testing. 18 experienced immune monitoring laboratories from 10 countries participated, and ImmuMap did well in a comparable analysis with an overall maximal proficiency score. For further details see http://www.immudex.com/media/58254/immudex-report-mhc-multimer-proficiency-panel-2017.pdf
and look for lab ID 516.
The MHC multimer proficiency panel initiative was organized by our collaborator Immudex and originally initiated by CIC (the Cancer Immunotherapy Consortium of the Cancer Research Institute, USA) and the CIMT (Association for Cancer Immunetherapy, Europe).